Free Webex Call
United Kingdom blood glucose monitoring devices market might register an impressive CAGR during the forecast period, 2023-2027, to establish growth due to increasing instances of diabetes. Rapidly growing population that suffers from the type 2 diabetes is a major factor that drives the growth of the United Kingdom blood glucose monitoring devices market in the upcoming five years. Increasing instances of diabetes among the population is actively facilitating the growth of the market. Also, demand for non-invasive medical equipment that can calculate and monitor blood glucose levels also supports the growth of the United Kingdom blood glucose monitoring devices market in the next five years. Consistent research and technological advancements in the product and its development further aids market growth. Advancements like non-invasive, minimally invasive nature of the products, higher accuracy of the devices, battery powered products, mobile application based analysis and data keeping, etc. further fuels the growth of the United Kingdom blood glucose monitoring devices market in the future five years.Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
The United Kingdom blood glucose monitoring devices market is segmented by product type, application, end user, competitional landscape, and regional distribution. Based on product type, the market is bifurcated into self-blood glucose monitoring devices and continuous glucose monitoring devices. Self-blood glucose monitoring devices include glucometers, test strips, and lancets. Self-blood glucose monitoring devices are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years due to increasing demand for glucometers. Among the sub-segments glucometers are anticipated to hold largest revenue shares due to technological advancements. Smartphone based applications that record the data, acts as display screen for the glucometer, and record keeping and sharing with online platforms such that regular reports could be made to the doctors, all aid the growth of the United Kingdom blood glucose monitoring devices market in the next five years. Continuous glucose monitoring devices include sensors, transmitters & receivers, and integrated insulin pumps. Continuous glucose monitoring devices may register significant growth due to increasing demand for the wearable monitoring devices among the population. Sensors would hold the largest revenue among the sub-segment since the equipment requires periodic changes and thus increasing the demand for the same.
Abbott Laboratories Limited, Johnson & Johnson Limited, Medtronic UK, Roche Diagnostics Limited, Becton Dickinson U.K. Limited, Nipro Medical UK Limited, Bayer UK Limited, among others is a partial list of major market players responsible for the growth of United Kingdom blood glucose monitoring devices market.
Years considered for this report:
Historical Years: 2017-2020Base Year: 2021
Estimated Year: 2022E
Forecast Period: 2023F-2027F
Objective of the Study:
- To analyze the historical growth in the market size of the United Kingdom blood glucose monitoring devices market from 2017 to 2021.
- To estimate and forecast the market size of United Kingdom blood glucose monitoring devices market from 2022E to 2027F and growth rate until 2027F.
- To classify and forecast the United Kingdom blood glucose monitoring devices market based on product type, application, end user, region, and company.
- To identify the dominant region or segment in the United Kingdom blood glucose monitoring devices market.
- To identify drivers and challenges for the United Kingdom blood glucose monitoring devices market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the United Kingdom blood glucose monitoring devices market.
- To identify and analyze the profiles of leading players operating in the United Kingdom blood glucose monitoring devices market.
- To identify key sustainable strategies adopted by market players in United Kingdom blood glucose monitoring devices market.
The publisher performed both primary as well as exhaustive secondary research for this study. Initially, the publisher sourced a list of manufacturers across the country. Subsequently, the publisher conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, the publisher could include the manufacturers who could not be identified due to the limitations of secondary research. The publisher analyzed the manufacturers, distribution channels and presence of all major players across the country.
The publisher calculated the market size of the United Kingdom blood glucose monitoring devices market using a top-down approach, wherein data for various end-user segments was recorded and forecast for the future years. The publisher sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these products and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by the publisher.
Key Target Audience:
- Blood glucose monitoring devices manufacturers
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums, and alliances related to blood glucose monitoring devices
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as product manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
Report Scope:
In this report, United Kingdom blood glucose monitoring devices market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
United Kingdom Blood Glucose Monitoring Devices Market, By Product Type:
- Self-Blood Glucose Monitoring Devices
- Glucometers
- Test Strips
- Lancets
- Continuous Glucose Monitoring Devices
- Sensors
- Transmitters & Receivers
- Integrated Insulin Pumps
United Kingdom Blood Glucose Monitoring Devices Market, By Application:
- Type 1 Diabetes
- Type 2 Diabetes
- Gestational Diabetes
United Kingdom Blood Glucose Monitoring Devices Market, By End User:
- Home Care Settings
- Hospital
- Others
United Kingdom Blood Glucose Monitoring Devices Market, By Region:
- London
- East Anglia
- Southwest
- Southeast
- Scotland
- East Midlands
- Yorkshire & Humberside
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in United Kingdom Blood glucose monitoring devices market.Available Customizations:
With the given market data, the publisher offers customizations according to a company’s specific needs. The following customization options are available for the report:Company Information
Detailed analysis and profiling of additional market players (up to five).Table of Contents
1. Product Overview2. Research Methodology3. Executive Summary4. Impact of COVID-19 on United Kingdom Blood Glucose Monitoring Devices Market5. Voice of Customer10. Market Trends & Developments11. Policy & Regulatory Landscape12. Pricing Analysis13. Import-Export Analysis14. United Kingdom Economic Profile
6. United Kingdom Blood Glucose Monitoring Devices Market Outlook
7. United Kingdom Self Blood Glucose Monitoring Devices Market Outlook
8. United Kingdom Continuous Blood Glucose Monitoring Devices Market Outlook
9. Market Dynamics
15. Competitive Landscape
16. Strategic Recommendations
Companies Mentioned
- Abbott Laboratories Limited
- Johnson & Johnson Limited
- Medtronic UK
- Roche Diagnostics Limited
- Becton Dickinson U.K. Limited
- Nipro Medical UK Limited
- Bayer UK Limited